For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260115:nRSO9510Oa&default-theme=true
RNS Number : 9510O Mpac Group PLC 15 January 2026
15 January 2026
AIM: MPAC
Mpac Group plc
(''Mpac'', "the Company" or "the Group")
Full Year Trading Update
and
Notice of Results
FY25 trading performance in line with market expectations, with improving
operating margins and a stabilised order book
Mpac Group plc, a global leader in high-speed packaging and automation
solutions, today announces a trading update (unaudited) for the year ended 31
December 2025 ("FY25").
The Group expects that it will report revenues of c£170m (FY24: £122.4m) and
underlying profit before tax in line with market expectations of £13.5m
(FY24: £10.5m). Following the actions undertaken in H1, profit before tax
improved substantially in H2 25, aided by continued high level of customer
focus from our service teams, improving project margins and operational
efficiencies.
The Group closed 2025 with an order book stabilised at c.£92.0m, in line with
the position as of 30 June 2025 (HY25 £91.7m). Original Equipment ("OE")
order intake improved c25% in the second half of the year against H1 25,
following a slow first half as customers deferred capital investments due to
market uncertainty in response to US trade tariffs. The Group has a strong and
broad-based opportunity pipeline, with clear order intake targets, which we
expect will support our growth ambitions, albeit the Board is mindful of
ongoing uncertainty in end markets. Further good progress was made with the
Services business.
Deferrals of anticipated orders in Q4 25 resulted in lower customer deposits
and consequently resulted in a higher net debt, excluding leases of £47.7m.
Net debt is expected to reduce through 2026 given the make-up of the order
book and opportunity pipeline, combined with an ongoing focus on cost
management and cash collection. The Group continues to operate comfortably
within its banking covenants.
Mpac operates in the substantial growing markets of Healthcare and Food and
Beverage, although macro uncertainty remains, we start 2026 with good quote
activity, as well as an improved offering through combined product lines from
businesses acquired in 2024.
The opening order book, the prospect pipeline, and the actions taken in 2025
position the Group well to deliver on market expectations for the current
financial year and beyond.
Adam Holland, Chief Executive, commented:
"The Group has delivered full year performance in line with market
expectations, against the backdrop of macro-economic uncertainty, which led to
customers deferring expenditure. We took decisive actions to reduce operating
costs in the light of these near-term challenges. While we are mindful of the
ongoing uncertainty in end markets, we have a strong and broad-based
opportunity pipeline with clear order intake targets. Combined with a
relentless focus on cost and cash management we expect this will allow the
Group to make further progress in 2026. Looking further ahead, we remain
confident in delivering enhanced shareholder value through the Group's growth
strategy, driven by innovation, operational excellence and outstanding
customer service.''
The Group's full year results for the year ended 31 December 2025 are expected
to be announced on 21 April 2026.
For further information, please contact:
Mpac Group plc Tel: +44(0)24 7642 1100
Adam Holland, Chief Executive
Will Wilkins, Chief Financial Officer
Shore Capital (Nominated Adviser & Broker) Tel: +44(0)20 7408 4050
Advisory
Patrick Castle
Sophie Collins
Broking
Henry Willcocks
Panmure Liberum (Joint Broker) Tel: +44 (0) 20 3100 2000
Edward Mansfield
Will King
Freddy Wooding
Tavistock Tel: +44 (0) 20 7920 3150
Nick Dibden
Katie Hopkins
Grace Cooper
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TSTBIMRTMTIBBFF
Copyright 2019 Regulatory News Service, all rights reserved